DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Leukeran (Chlorambucil) - Current Clinical Trials

 
 



Leukeran Related Clinical Trials

Dose Escalation Study of Gleevec and Chlorambucil in Previously Treated Chronic Lymphocytic Leukemia Patients [Terminated]

Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial) [Active, not recruiting]

Chlorambucil + Lenalidomide and Lenalidomide Maintenance in Untreated Elderly With Chronic Lymphocytic Leukemia (CLL) [Completed]

A Phase II, Open Label, Single Arm, Multicenter Study of Chlorambucil in Japanese Previously Untreated Patients With Chronic Lymphocytic Leukemia [Completed]

TGR-1202, a PI3K Delta Inhibitor, in Combination With Obinutuzumab and Chlorambucil in Patients With Chronic Lymphocytic Leukemia (CLL) [Recruiting]

A Phase I/II, Open-label Study of Ofatumumab Added to Chlorambucil in Previously Untreated Japanese Patients With Chronic Lymphocytic Leukemia [Completed]

Trial Comparing Chlorambucil to Fludarabine in Patients With Advanced Waldenström Macroglobulinemia [Completed]

Randomized Trial of Chlorambucil Versus Chlorambucil Plus Rituximab Versus Rituximab in MALT Lymphoma [Active, not recruiting]

Safety and Efficacy of SDX-101 (R-Etodolac) in Combination With Chlorambucil, and That of Chlorambucil Alone, in Patients With Chronic Lymphocytic Leukemia (CLL) [Terminated]

Efficacy and Safety of Idelalisib in Combination With Obinutuzumab Compared to Chlorambucil in Combination With Obinutuzumab for Previously Untreated Chronic Lymphocytic Leukemia [Recruiting]

Study to Investigate Idelalisib in Combination With Chemotherapeutic Agents, Immunomodulatory Agents and Anti-CD20 Monoclonal Antibody (mAb) in Subjects With Relapsed or Refractory Indolent B-cell Non-Hodgkin's Lymphoma, Mantle Cell Lymphoma or Chronic Lymphocytic Leukemia [Completed]

A Trial Looking at Ofatumumab for People With Chronic Lymphocytic Leukaemia Who Cannot Have More Intensive Treatment [Recruiting]

This Trial is a Phase II Study of Chlorambucil and Subcutaneous Rituximab in Patients With Extranodal MALT Lymphoma [Recruiting]

Study of Obinutuzumab + Chlorambucil, ACP-196 + Obinutuzumab, and ACP-196 in Subjects With Previously Untreated CLL [Recruiting]

A Multi-Center Study of Ibrutinib in Combination With Obinutuzumab Versus Chlorambucil in Combination With Obinutuzumab in Patients With Treatment naïve CLL or SLL [Recruiting]

Chlorambucil in Treating Patients With Advanced Chronic Lymphocytic Leukemia [Active, not recruiting]

Fludarabine or Chlorambucil as First-Line Therapy in Treating Older Patients With Previously Untreated Chronic Lymphocytic Leukemia [Active, not recruiting]

Chlorambucil or Fludarabine as First-Line Therapy in Treating Patients With Previously Untreated Waldenstr�m Macroglobulinemia, Splenic Lymphoma, or Lymphoplasmacytic Lymphoma [Completed]

Chlorambucil Compared With Radiation Therapy in Treating Patients With Previously Untreated Stage III or Stage IV Follicular Lymphoma [Active, not recruiting]

A Study of MabThera Added to Bendamustine or Chlorambucil in Patients With Chronic Lymphocytic Leukemia (MaBLe) [Completed]

Chlorambucil Compared With No Further Therapy Following Anti-Helicobacter Therapy in Treating Patients With Low-Grade Lymphoma of the Stomach [Active, not recruiting]

A Study of MabThera (Rituximab) Plus Chlorambucil in Patients With Previously Untreated Chronic Lymphocytic Leukemia. [Completed]

Retrospective Study: Efficacy and Safety of Chlorambucil + Rituximab in CLL Patients [Recruiting]

A Study to Compare Mabthera (Rituximab), Fludarabine and Cyclophosphamide to Mabthera and Chlorambucil in Patients With Chronic Lymphocytic Leukemia and Unfavourable Somatic Status [Active, not recruiting]

An Expanded Access, Open-Label Study of Obinutuzumab (GA101) Plus Chlorambucil in Patients With Previously Untreated Chronic Lymphocytic Leukemia [Approved for marketing]

Efficacy/Safety of Frontline Alemtuzumab (Campath, MabCampath) vs Chlorambucil in Patients With Progressive B-Cell Lymphocytic Leukemia [Completed]

A Study Evaluating the Safety of Tocilizumab Plus Standard of Care Premedication Given Before Obinutuzumab+Chlorambucil Administration in Patients With Untreated B-Cell Chronic Lymphocytic Leukemia Who Have Comorbidities [Recruiting]

A Study to Compare the Efficacy and Safety of Obinutuzumab + GDC-0199 Versus Obinutuzumab + Chlorambucil in Patients With Chronic Lymphocytic Leukemia [Recruiting]

Bendamustine Hydrochloride Injection for Previously Untreated Chronic Lymphocytic Leukemia [Recruiting]

Bendamustine Hydrochloride Injection for Initial Treatment of Chronic Lymphocytic Leukemia [Completed]

An Open-label Extension Study in Patients 65 Years or Older With Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL) Who Participated in Study PCYC-1115-CA (PCI-32765 Versus Chlorambucil) [Enrolling by invitation]

A Study of MabThera (Rituximab) Plus Chlorambucil in Patients With Chronic Lymphocytic Leukemia. [Completed]

Treatment of Mantle Cell Lymphoma at Diagnosis for Patients Under 65 Years [Completed]

Chemotherapy in Treating Patients With Newly Diagnosed Chronic Lymphocytic Leukemia [Completed]

A Study to Determine the Efficacy of Lenalidomide Versus Investigator's Choice in Patients With Relapsed or Refractory Mantle Cell Lymphoma (MCL) [Active, not recruiting]

Combination Chemotherapy With or Without Interferon Alfa in Treating Patients With Low-Grade Non-Hodgkin's Lymphoma [Active, not recruiting]

Combination Chemotherapy and/or Radiation Therapy in Treating Young Patients With Hodgkin's Lymphoma [Active, not recruiting]

Mycophenolate Mofetil in Membranous Nephropathy and Focal Segmental [Completed]

Radiation Therapy or Combination Chemotherapy in Treating Young Patients With Hodgkin's Lymphoma [Active, not recruiting]

Combination Chemotherapy With or Without Radiation Therapy and Peripheral Stem Cell Transplant in Treating Children With Hodgkin's Lymphoma [Active, not recruiting]

Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage III or Stage IV Non-Hodgkin's Lymphoma [Active, not recruiting]

Combination Chemotherapy in Treating Patients With Advanced Hodgkin's Disease [Completed]

Multicenter Uveitis Steroid Treatment (MUST) Trial [Completed]

Study: Treatment of Relapsed Lymphoid Malignancies With an Anti-Angiogenic Approach [Terminated]

Rituximab, Bortezomib,Bendamustine , Dexamethasone, Patients With Mantle Cell Lymphoma [Completed]

Bendamustine Versus Fludarabine in Chronic Lymphocytic Leukemia (CLL) [Completed]

Yttrium Y 90 Ibritumomab Tiuxetan and Rituximab in Treating Patients With Previously Untreated Marginal Zone Lymphoma [Active, not recruiting]

RESPeCT: Revlimid Early Stage Poor Prognosis Chronic Lymphocytic Leukaemia (CLL) Trial [Terminated]

High Dose Cyclophosphamide for Treatment of Scleroderma [Completed]

Sirolimus Therapy for Idiopathic and Lupus Membranous Nephropathy [Completed]

A Safety Study of Obinutuzumab Alone or in Combination With Chemotherapy in Patients With Chronic Lymphocytic Leukemia [Recruiting]

Study Evaluating Temsirolimus (CCI-779) In Mantle Cell Lymphoma (MCL) [Completed]

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017